Format

Send to

Choose Destination
BMC Med Genet. 2009 May 31;10:47. doi: 10.1186/1471-2350-10-47.

Functional polymorphism of the NFKB1 gene promoter is related to the risk of dilated cardiomyopathy.

Author information

1
Laboratory of Molecular Translational Medicine, West China Second University Hospital, Sichuan University, Chengdu, PR China. zb630@163.com

Abstract

BACKGROUND:

Previous studies in experimental and human heart failure showed that nuclear factor kappa B (NF-kappaB) is chronically activated in cardiac myocytes, suggesting an important involvement of NF-kappaB in the cardiac remodeling process. A common insertion/deletion (-94 insertion/deletion ATTG, rs28362491) located between two putative key promoter regulatory elements in the NFKB1 gene was identified which seems to be the first potential functional NFKB1 genetic variation. The main goal of the present investigation was to investigate the NFKB1 -94 insertion/deletion ATTG polymorphism in relation to risk of dilated cardiomyopathy (DCM).

METHODS:

A total of 177 DCM patients and 203 control subjects were successfully investigated. The NFKB1 -94 insertion/deletion ATTG polymorphism was genotyped by using PCR-PAGE.

RESULTS:

Genotype frequency of NFKB1 -94 insertion/deletion ATTG polymorphism in DCM patients was significantly different from that in control subjects (P = 0.015) and the ATTG2 carrier (ATTG1/ATTG2 + ATTG2/ATTG2) was susceptible to DCM.

CONCLUSION:

Our data suggested that NFKB1 -94 insertion/deletion ATTG polymorphism is associated with DCM.

PMID:
19480714
PMCID:
PMC2692851
DOI:
10.1186/1471-2350-10-47
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center